Free Trial
→ Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (From Banyan Hill Publishing) (Ad)tc pixel

EUROFINS SCIENT (OTCMKTS:ERFSF) Shares Gap Down - Here's What Happened

Written by MarketBeat
September 29, 2025
EUROFINS SCIENT logo with Medical background

Key Points

  • EUROFINS SCIENT shares gapped down, opening at $70.06 from a previous close of $72.92, and last traded at $71.35 with low trading volume of 67 shares.
  • Analysts maintain an average rating of "Hold" for the stock, with Citigroup reaffirming a "neutral" rating and one analyst issuing a "Strong Buy" rating.
  • The company possesses a current ratio of 1.26 and a debt-to-equity ratio of 0.77, indicating moderate financial stability and leverage.
  • MarketBeat previews top five stocks to own in October.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report)'s stock price gapped down prior to trading on Monday . The stock had previously closed at $72.92, but opened at $70.06. EUROFINS SCIENT shares last traded at $71.35, with a volume of 67 shares trading hands.

Analysts Set New Price Targets

Separately, Citigroup reaffirmed a "neutral" rating on shares of EUROFINS SCIENT in a report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold".

Read Our Latest Research Report on EUROFINS SCIENT

EUROFINS SCIENT Stock Performance

The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77. The business's fifty day simple moving average is $76.46 and its two-hundred day simple moving average is $67.84.

About EUROFINS SCIENT

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.